Holdings

Gilead Sciences, Inc.

As of Sep 30, 2026, Gilead Sciences, Inc. reported 4 positions worth US$1.46B. Largest: Arcus Biosciences, Inc., Lakefront Biotherapeutics and Assembly Biosciences, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Arcus Biosciences, Inc.31.4MUS$812Mno changeSep 30, 2026
Lakefront Biotherapeutics16.7MUS$501Mno changeSep 30, 2026
Assembly Biosciences, Inc.4.98MUS$117Mno changeSep 30, 2026
Kyverna Therapeutics, Inc.4.13MUS$28.1Mno changeSep 30, 2026